|Year : 2018 | Volume
| Issue : 1 | Page : 25-31
Photobiomodulation therapy for diabetic macular edema: Fourier transform infrared spectroscopy study
Salwa A Abdelkawi1, Aziza A El Saeid2, Ahlam M El-Rashedi2, Maha S Abd-Eldaiem1
1 Biophysics and Laser Science Unit, Research Institute of Ophthalmology, Giza, Egypt
2 Physics Department, Faculty of Science, AL Azhar University (Girls), Cairo, Egypt
|Date of Submission||27-Dec-2017|
|Date of Acceptance||03-Jun-2018|
|Date of Web Publication||19-Jul-2018|
Salwa A Abdelkawi
Biophysics and Laser Science Unit, Vision Sciences Department, Research Institute of Ophthalmology, 2 Elahram Street, Giza, 12511
Source of Support: None, Conflict of Interest: None
Background/Aim Photobiomodulation (PBM) is the application of low-level light that has a beneficial biological effect, such as to relieve pain, to heal existing tissue damage, and to inhibit the development of tissue pathology. The aim of the current study is to evaluate the effect of PBM therapy on diabetic macular edema (DME) in albino rats as assessed by Fourier transform infrared spectrum.
Materials and methods Twenty-five albino rats with the same sex (200±20 g) were involved in this study. Diabetes was induced in albino rats after intraperitoneal injection of 55 mg/kg streptozotocin. The experimental animals were divided into three main groups: (i) control group, (ii) DME group that did not received any treatment, and (iii) DME group that was exposed to two sessions/week of 660-nm low-level laser source for a period of 2 weeks. The rat’s eye received a power of 5 mW/cm2 for 90 s, with a total energy of 450 mJ, in each session. Fourier transform infrared spectrum analysis was applied after 2 weeks for comparison between the diabetic and PBM-treated groups.
Results The results confirmed that DME was associated with changes in the retina structure that appeared after receiving a single dose of streptozotocin 55 mg/kg. These changes obviously appeared in the NH–OH as shown in strO–H (P<0.05), strO–Hsym (P<0.01), C–Hring (P<0.01), CH stretching, fingerprint, and amide I regions. Treatment with PBM significantly improved most of the amide I components except the first peak of β-turn and formation of new bands corresponding to β-sheet.
Conclusion The treatment with PBM by using low-level diode laser was associated with different beneficial effects on the retina constituents, as showed by the obvious improvement in the retinal protein secondary structure using Fourier transform infrared analysis. More PBM sessions and long-term follow-up are needed for use of the PBM therapy as a treatment method.
Keywords: diabetic macular edema, Fourier transform infrared, photobiomodulation, retina
|How to cite this article:|
Abdelkawi SA, El Saeid AA, El-Rashedi AM, Abd-Eldaiem MS. Photobiomodulation therapy for diabetic macular edema: Fourier transform infrared spectroscopy study. J Arab Soc Med Res 2018;13:25-31
|How to cite this URL:|
Abdelkawi SA, El Saeid AA, El-Rashedi AM, Abd-Eldaiem MS. Photobiomodulation therapy for diabetic macular edema: Fourier transform infrared spectroscopy study. J Arab Soc Med Res [serial online] 2018 [cited 2018 Dec 9];13:25-31. Available from: http://www.new.asmr.eg.net/text.asp?2018/13/1/25/237215
| Introduction|| |
Diabetic macular edema (DME) is the most common cause of vision loss in the working age population, 20–74 years old. DME occurs because of an increase of water in the retinal tissue, subsequent by an increase in its thickness. This increase in water content of the retinal tissue may be initially intracellular (cytotoxic edema) or extracellular (vasogenic edema) . It is mainly due to sustained hyperglycemia causing a breakdown in the blood–retinal barrier (BRB). This breakdown of vessel walls leads to accumulation of fluids in extracellular space, and the ultimate formation of DME .
Photobiomodulation (PBM) is the application of low-level light that has a biological effect. Numerous studies have shown that light in the far-red to near-infrared region of the spectrum (630–1000 nm) can have beneficial effects in vitro and in vivo to heal existing tissue damage and to inhibit the development of tissue pathology ,,,.
Retina is ∼0.5 mm thick with an optic nerve at the center. There are slightly oval-shaped, blood vessel-free reddish spots (the fovea) at the center of the area known as the macula. Photoreceptors (the rods and cones) are present at the exterior of retina, and the absorption of photons by the visual pigment of the photoreceptors is converted to an electrical signal that can stimulate all the neurons of the retina. Central retina close to the fovea is much thicker than peripheral retina. This is owing to the increased stuffing density of photoreceptors, specially the cones. In the past 10 years, there has been a cumulative interest in the use of 670-nm red light to manage retinal injuries. Early reports verified the ability of 670-nm red light to diminish damaging effects of methanol intoxication in rat retinas. More recent studies have shown that 670-nm light treatment provides significant protection to photoreceptors in retinas exposed to damaging levels of light . This study aimed to explore the efficacy of PBM therapy in treatment of DME as assessed by Fourier transform infrared spectroscopy (FTIR).
| Materials and methods|| |
Twenty-five female albino rats were involved. The rat’s ages ranged from 8 to 12 weeks, and their mean weight was 200±20 g. The rats were supplied by the animal house of Research Institute of Ophthalmology, Giza, Egypt. The rats were maintained in a standard 12-h light–dark cycle with free access to water and balanced diet at a temperature of 30±2°C and 50% humidity. All rats’ eyes were examined by slit lamp biomicroscope before induction of diabetes. The results exhibited no signs of edema or intraocular inflammation in all eyes. The rats were divided into three groups: (i) control group (shame control) which did not receive any treatment (n=5 rat); (ii) 2-week diabetic group (n=10), which was intraperitoneal injected with 55 mg/kg of streptozotocin in 0.1 mol/l freshly prepared citrate buffer pH=4.4; and (iii) diabetic group (n=10) treated with PBM for 2 weeks. Fasting blood glucose levels were monitored after 72 h of streptozotocin injection, and animals with blood glucose levels of more than 400 mg/dl were selected. The diabetic rats were followed up for 8 weeks using slit lamp examination till the establishment of macular edema and then treated with PBM therapy.
Low-level diode laser was generated and calibrated to deliver 660-nm light at a power of 5 mW/cm2, for 90 s (two sessions/week), using a system consisting of laser prop and convex lens for beam focusing. The distance between the laser prop and rat eye was ∼7–9 cm. The weekly radiant exposure energy was thus 900 mJ/cm2 or (∼1 J/cm2) for each eye. The rats were exposed to this radiation for 2 weeks. This protocol has been documented and selected to decrease retinal toxicity and light damage ,.
Extraction of the retina
At the end of the estimated period, the albino rats were decapitated; the eyes were enucleated and then the retinas were carefully removed from the posterior chamber of the eye. Extraction of retinal cells was carried out and directly prepared for FTIR.
Fourier transformer infrared spectroscopy
Samples of retinal cells were freeze dried and then mixed with KBr powder (98 mg KBr: 2 mg of lyophilized retina) to prepare the KBr disks for FTIR measurements. FTIR spectra were measured in the range of 4000–1000/cm at room temperature using ThermoNicolet iS5 FTIR spectrometer (Thermo Fisher Scientific Inc., Madison, Wisconsin, USA) with effective resolution of 2/cm. Hundred sample interferograms were recorded for each spectrum to enhance the apparent resolution of a spectrum or decrease the width of all lines contributing to the investigated spectral range. The spectrometer is operated under a continuous dry nitrogen gas purge to get rid of interference from atmospheric carbon dioxide and water vapor. The data were baseline corrected and smoothened by Savitzky–Golay to remove the noise before Fourier transformation. The obtained group spectrum was normalized and analyzed for the following spectral regions: (i) NH–OH region at 3700–3000/cm; (ii) CH stretching region at 3000–2800/cm; and (iii) the fingerprint region at 1800–1000/cm, which includes the amide I band (1800–1600/cm). The average of the individual spectrum for each group was obtained using Origin Pro 9 software (OriginLab Corporation, Northampton, MA 01060, USA).
Data were expressed as mean±SD. The analysis of variance procedure was used for comparison between different groups, where a commercially available software package (SPSS-11, for windows; SPSS Inc., Chicago, USA) was used. The result was considered significance at P less than 0.05.
| Results|| |
[Figure 1] showed the IR frequency range at 3800–3000/cm corresponding to stretching NH–OH region. [Table 1] showed the wave numbers and bandwidths of the deconvoluted peaks for control, non-PBM-treated diabetic, and diabetic group exposed to PBM therapy after 2 weeks. By applying the curve enhancement procedure, the control retina revealed four characteristic bands appeared at 3606±4, 3455±9, 3240±8, and 3076±7/cm corresponding to O–Hstr, strO–H, strO–Hsym, and C–Hring, respectively . For the non-PBM-treated DME group, the band at 3455/cm attributed to strO–H was shifted to 3476±2/cm and its bandwidth was decreased (P<0.05). In addition, the band corresponding to strO–Hsym was decreased in both wave number and bandwidth (P<0.01). Moreover, the band of C–Hring at 3076/cm increased in bandwidth (P<0.01) with formation of new band at 3313±4/cm corresponding to StrNHasym.
|Figure 1 FTIR of the retina for control, DME, and DME+PBM in the NH–OH region (3800–3000/cm) after 2 weeks. DME, diabetic macular edema; FTIR, Fourier transform infrared spectroscopy; PBM, photobiomodulation.|
Click here to view
|Table 1 Wave number and bandwidth and the different component of the NH–OH region (3800–3000/cm) for all studied groups|
Click here to view
In PBM group, the bands of strO–H at 3455±9/cm and strO–Hsym were obviously improved in their vibrational frequencies and bandwidths. Moreover, the bandwidth of the first strO–H was significantly decrease (P<0.05) and the band corresponding to the C–Hring band was missing.
CH stretching region
[Figure 2] showed the CH stretching region at frequency range of 3000–2800/cm for the retina of the control, non-PBM-treated diabetic, and diabetic group treated with PBM after 2 weeks. The profile of the control group revealed the presence of three peaks centered at 2963±2, 2926±3, and 2860±2/cm corresponding to CH3 asymmetric, CH2 asymmetric, and CH2 symmetric vibration modes ([Table 2]), respectively .
|Figure 2 FTIR of the retina for control, DME, and DME+PBM in the CH stretching region (3000–2800/cm) after 2weeks. DME, diabetic macular edema; FTIR, Fourier transform infrared spectroscopy; PBM, photobiomodulation.|
Click here to view
|Table 2 Wave numbers and bandwidths of CH stretching region for control, diabetic macular edema, and PBM-treated diabetic macular edema groups after 2 weeks|
Click here to view
In DME group, the bands corresponding to CH3 asymmetric, CH2 asymmetric, and CH2 symmetric showed nonsignificant changes in their wave numbers and bandwidth except the bandwidth of CH2 symmetric, which showed significant decrease (P<0.05). Moreover, two new bands at 2895±1 and 2870±1/cm corresponding to CHstre and symCH3 appeared, indicating an environmental change. The PBM group showed significant decrease in the bandwidth of CH2 symmetric (P<0.05) and appearance of new band at 2874±1/cm corresponding to CH3 symmetric vibration.
[Figure 3] showed the fingerprint region (1800–1000/cm) for the control, non-PBM-treated diabetic, and diabetic group treated for 2 weeks by PBM therapy. The control group revealed the presence of 9 bands: (i) C═O stretching vibrations mode of carboxylic acid of the amino acid at 1720±1/cm, (ii) amide I at 1648±1/cm, (iii) the amide II (NH bending and CH stretching) at 1544±5/cm, (iv) CH2 bending at 1458±5/cm, (v) COOsym at 1403±5/cm, (vi) CH3 deformation at 1301±2/cm, (vii) strPO2asym at 1230±5/cm, (viii) COOasym at 1230±1, and (ix) symPO2 at 1083±1/cm ,.
|Figure 3 FTIR of rat’s retina for control (nine peaks), DME, and DME after 2 weeks of PBM therapy, in the fingerprint region (1800–1000/cm). DME, diabetic macular edema; FTIR, Fourier transform infrared spectroscopy.|
Click here to view
As shown in [Table 3], in the non-PBM-treated DME group, the amid I and amide II located at 1648±1 and 1544±5/cm, respectively, were shifted to 1644±1 and to 1549±1/cm, respectively, and their bandwidths could be considered with no changes. Although the control and diabetic groups were characterized by the same number of peaks (nine peaks), the curve enhancement procedure used to resolve the overlapped peaks indicated disappearance of CH2 bending mode and formation of additional new band at 1041/cm, which may be assigned to C−O−C group. The band corresponding to COOsym at 1403±5/cm was characterized by increased band position and bandwidths. CH3 deformation at 1301±2/cm and strPO2asym at 1230±5/cm were significantly changed in their bandwidths (P˂0.05 and ˂0.01, respectively), whereas the band corresponding to COOasym showed nonsignificant change in its bandwidth (P˃0.05).
|Table 3 Wave number and bandwidth of fingerprint region for control, DME, and DME group exposed to photobiomodulation therapy after 2 weeks|
Click here to view
After treatment of the retinal macular edema for two weeks with PBM therapy, the absorption band that ascribed to C═O stretching vibration mode of carboxylic acid of the amino acid and the amide I was significantly shifted to lower wave number (P˂0.05). The amide II, CH2 bending, COOsym, CH3 deformation, and StrPO2asym have nonsignificant change in their vibrational frequencies and in their bandwidths.
Amide I region
[Figure 4] showed the analysis of the amide I band after 2 weeks by using the curve enhancement procedure. The data revealed that the control amide I band can be resolved into five structural components: (i) two bands located at 1979±3 and 1666±3/cm for β-turn, (ii) one band located at 1651±1/cm for α-helix, and (iii) two bands located at 1637±3 and1623±3/cm for β-sheet, respectively ,,.
|Figure 4 FTIR of rat’s retina in the amide I (1700–1600 cm) region for control, DME and DME group exposed to photobiomodulation therapy after 2 weeks. DME, diabetic macular edema.|
Click here to view
Analysis of amide I bands revealed the following: (i) the β-turn (first peak component at 1679/cm) showed significant decrease in their bandwidths in both non-PBM-treated DME and PBM-treated DME groups (P˂0.01), (ii) the second peak corresponding to β-turn showed significant change in bandwidths of both non-PBM-treated DME and PBM-treated DME group (P˂0.05), (iii) the band corresponding α-helix showed nonsignificant change (P˃0.05), (iv) the band width of the first peak of β-sheet was increased in diabetic group and improved after PBM therapy, and (v) finally, one additional band corresponding to β-sheet appeared in both non-PBM-treated diabetic group and PBM-treated diabetic group at 1608 and 1610/cm, respectively.
| Discussion|| |
FTIR is appropriate as an investigation to detect the different secondary structures of proteins and polypeptides .
In the present study, all the NH–OH region components changed in DME, as shown in strO–H (P˂0.05), strO–Hsym (P˂0.01), and C–Hring (P˂0.01), along with the formation of a new band corresponding to strNHasym. After treatment with PBM, the bands of strO–H and strO–Hsym were obviously improved in their vibrational frequencies and bandwidths and the band corresponding to the C–Hring band was missed. In the NH–OH region, the NH bond exists in several membrane constituents that contain protein and lipid. Therefore, low-level laser exposure may lead to changes in membrane structure of retinal cells. Moreover, the change in the vibrational frequencies of strO–H and strO–Hsym indicated that the hydrogen bond has been destructed and/or weakened ,.
In non-PBM-treated diabetic group, the bandwidth of CH2 symmetric at 2860/cm was decreased (P˂0.05) in addition to the formation of two new bands at 2895±1 and 2870±1/cm corresponding to CHstr and symCH3, respectively, indicating an environmental change leading to disorder in the lipid hydrocarbon chains. On the contrary, the appearance of new band at 2874±1/cm corresponding to CH3 symmetric vibration in the PBM-treated group, indicating change in end methyl group of the hydrocarbon chain, may be due to laser exposure.
By analysis of the fingerprint region ([Table 3]), it is found that the DME induced obvious changes in the vibrational frequencies and bandwidths of some estimated components. The shift of the C═O to 1713±2/cm, and increase in its bandwidth may be connected with destruction of old H-bond and formation of new one . Additionally, disappearance of CH2 bending mode can be attributed to the retina cell membrane disorder, and the formation of additional new band at 1041/cm may be assigned to C−O−C group . The change in bands corresponding to COOsym, CH3 deformation, and C═C stretching mode could be attributed to modification and redistribution of the intensities of different components after establishment of macular edema. The change occurring in the symmetric stretching vibration of symPO2 at 1083/cm was characterized by increased band position, and the bandwidth seems to be connected with spatial changes in the position of the phosphate groups in the protein helix . The treatment of DME with PBM therapy induced improvement in most bands of the fingerprint region except the absorption band of 1720/cm which ascribed to C═O stretching vibrations mode of carboxylic acid of the amino acid, and the amide I appeared at 1648/cm. The remained structural changes of the C═O and amide I after PBM therapy may be related to a tendency to remain after treatment, so they have irreversible nature or more sessions of low-level therapy (PBM) are required.The secondary structure of the proteins depended on the amide I mode in the 1800–1600/cm spectral region. The results presented in [Figure 4] and [Table 4] showed that the protein secondary structure was affected in both DME and after PBM therapy where there are changes in the β-sheet and β-turn bandwidths. Treatment with PBM therapy significantly improved the first peak of β-sheet, with formation of new bands corresponding to β-sheet appeared in both non-PBM-treated diabetic group and PBM-treated diabetic group at 1610 and 1608/cm, respectively. Furthermore, the increase in β-sheet structure leads to the splitting or formation of new band of β-sheet in the DME, increasing the disorder of the helical structure, and development of disordered chains aggregates . The formation of this β-sheet structure remains irreversible even after treatment with PBM, and all bandwidths showed significant changes assumed to be due to vibrational motion.
|Table 4 Wave numbers and bandwidth of amide I (1700–1600/cm) region for control, DME, and DME group exposed to photobiomodulation therapy after 2 weeks|
Click here to view
| Conclusion|| |
The results obtained in this work indicate that DME induced changes in the NH–OH and the CH stretching region components even after treatment with PBM. Therefore, low-level laser exposure may lead to changes in membrane structure of retinal cells and destructed and/or weakened hydrogen bond. DME induced obvious changes in the vibrational frequencies and bandwidths in the fingerprint region. Additionally, retina cell membrane disorder presents modification and redistribution of the intensities of different components after establishment of macular edema and spatial changes in the position of the phosphate groups in the protein helix. PBM therapy induced improvement in most bands of the fingerprint region, except C═O stretching vibrations and the amide I. The last finding in this study concluded that DME induced progressive changes on the secondary structure of proteins in the amide I spectral region where there were changes in the β-sheet and β-turn. Treatment with PBM significantly improved most of the amide I components except the first beak of β-turn and new bands corresponding to β-sheet. Alternatively, it is not clear if they have irreversible nature or more PBM sessions are needed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Lobo C, Pires I, Cunha-Vaz J. Diabetic macular edema. In: Bernardes R, Cunha-Vaz J, editors. Optical coherence tomography. Berlin Heidelberg: Springer 2012. pp. 1–21.
Seethala A, Ness S, Subramanian M. Current treatments in diabetic macular edema. J Endocrinol Diab 2015; 2:6.
Saliba A, Du Y, Liu H, Patel S, Roberts R, Berkowitz BA, Kern TS. Photobiomodulation mitigates diabetes-induced retinopathy by direct and indirect mechanisms: evidence from intervention studies in pigmented mice. PloS one 2015; 10:e0139003.
Anders JJ, Lanzafame RJ, Arany PR. Low-level light/laser therapy versus photobiomodulationtherapy. Photomed Laser Surg 2015; 33:183–184.
Glazov G, Yelland M, Emery J. Low-level laser therapy for chronic non-specific low back pain: A meta-analysis of randomized controlled trials. Acupunct Med 2016; 34:328–341.
Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American college of physicians. Ann. Intern. Med 2017; 166:514–530.
Albarracin R, Natoli R, Rutar M, Valter K, Provis J. 670 nm light mitigates oxygen-induced degeneration in C57BL/6J mouse retina. BMC Neurosci 2013; 14:125.
Albarracin R, Eells J, Valter K. Photobiomodulation protects the retina from light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci 2011; 52:3582–3592.
Eells JT, Henry MM, Summerfelt P, Wong-Riley MTT, Buchmann EV, Kane M et al.
Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci USA 2003; 100:3439–3444.
Dovbeshko GI, Gridina NY, Elena B, Kruglova EB, Pashchuk OP. FTIR spectroscopy studies of nucleic acid damage. Talanta 2000; 53:233–246.
Coates J. Interpretation of infrared spectra, a practical approach. In: Mayer RA, editor. Encyclopedia of analytical chemistry. Chichester: John Wiley & Sons Ltd; 2000. pp. 10815–10837.
Mahmoud SS, El-Sakhawy E, Abdel-Fatah ES, Kelany AM, Rizk MR. Effectof low dose of Gamma-radiation on erythrocytes membrane. Radiat Environ Biophys 2011; 50:189–198.
Jackson M, Montsch H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit Rev Biochem Mol Biol 1995; 30:95–120.
Das KP, Choo-Smith LP, Petrash JM, Surewicz WK. Insight into the secondary structure of non-native proteins bound to a molecular chaperone α-crystalline. An isotope − edited infrared spectroscopic study. J Biol chem 1999; 274:33209–33212.
Haris P., Chapman D. Analysis of polypeptide and protein structures using Fourier transform infrared spectroscopy. Methods Mol Biol 1994; 22:183–202.
Yang L, Xu Y, Su Y. Study on the variations of molecular structures of some biomolecules induced by free electron laser using FTIR spectroscopy. Nucl Instrum Methods Phys Res 2003; 258:362–368.
Lin SY, Lee SM, Li MJ, Liang RC. Fourier transform infrared spectral evidences for protein conformational changes in immature cataractous human lens capsules accelerated by myopia and/or systemic hypertension. Spectrochim Acta A Mol Biomol Spectrosc 1997; 53:1507–1513.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2], [Table 3], [Table 4]